Atlas Trials

Discontinuation of Maintenance HER-2 Directed Therapy in Long-Term Survivors of Metastatic HER-2 Positive Breast Cancer

Clinical trial NCT05959291 · RECRUITING

Trial details

NCT number
NCT05959291
Sponsor
University of Miami
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
HER2-positive Metastatic Breast CancerStage IV Breast Cancer
Start date
2023-07-17
Primary completion
2026-07-31
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.